nach oben

Neurological Sciences

Erschienen in:

13.08.2021 | Original Article

Clinicopathological features of neuronal intranuclear inclusion disease diagnosed by skin biopsy

verfasst von: Gao-Jia Zhang, Di Wu, Yi-Xin Zhu, Hai-Feng Ni, Zhi-Jun Zhang

Erschienen in: Neurological Sciences | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Study objectives

Neuronal intranuclear inclusion disease (NIID) is a rare progressive neurodegenerative disorder, with complex and diverse of clinical manifestations characterized by eosinophilic hyaline inclusions in neurons and somatic cells. Due to the improvement in diagnostic methods, NIID is being increasingly diagnosed.

Methods

Herein, we reported three NIID cases, which were diagnosed by skin biopsy and FMR1 gene, after DWI showed the characteristic corticomedullary junction hyperintensity. Then we reviewed all the published cases of NIID in PubMed, which were diagnosed by the same method.

Results

We discussed 15 NIID cases, including three cases diagnosed by us. The average age was 63.4 ± 14.0 years. The average time from onset of symptom to diagnosis was 5.4 ± 7.9 years. Nine cases had dementia or cognitive impairment. Three cases presented with encephalitis. Three cases showed bladder dysfunction and two cases only presented with dizziness and headache. Two cases showed acute neurological deficit mimicking stroke. All cases were diagnosed by skin biopsy, after DWI showed abnormal corticomedullary junction hyperintensity. Ten cases showed inclusions in sweat gland cells, and seven cases in adipocytes, sweat gland cells, and fibroblasts. EMG was performed in five cases, four of whom had abnormal results, showing simultaneous involvement of motor and sensory nerves.

Conclusions

The results indicated that inclusions were more easily detected in sweat gland cells in skin biopsy. The early stage of NIID could only characterized by autonomic nerve function involvement. Combined autonomic nerve dysfunction might be another relatively common manifestation in NIID.

Motoki M, Nakajima H, Sato T, Tada M, Kakita A, Arawaka S (2018) Neuronal intranuclear inclusion disease showing intranuclear inclusions in renal biopsy 12 years earlier. Neurology 91:884–886CrossRef

Paviour DC, Revesz T, Holton JL, Evans A, Olsson JE, Lees AJ (2005) Neuronal intranuclear inclusion disease: report on a case originally diagnosed as dopa-responsive dystonia with Lewy bodies. Mov Disord 20:1345–1349CrossRef

Mori F, Miki Y, Tanji K, Ogura E, Yagihashi N, Jensen PH et al (2011) Incipient intranuclear inclusion body disease in a 78-year-old woman. Neuropathology 31:188–193CrossRef

Lindenberg R, Rubinstein LJ, Herman MM, Haydon GB (1968) A light and electron microscopy study of an unusual widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection. Acta Neuropathol 10:54–73CrossRef

Tian Y, Wang JL, Huang W, Zeng S, Jiao B, Liu Z et al (2019) Expansion of human-specific GGC repeat in neuronal intranuclear inclusion disease-related disorders. Am J Hum Genet 105:166–176CrossRef

Sone J, Mitsuhashi S, Fujita A, Mizuguchi T, Hamanaka K, Mori K et al (2019) Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet 51:1215–1221CrossRef

Deng JW, Gu ML, Miao Y, Yao S, Zhu M, Fang P et al (2019) Long-read sequencing identified repeat expansions in the 5′ UTR of the NOTCH2NLC gene from Chinese patients with neuronal intranuclear inclusion disease. J Med Genet 56:758–764CrossRef

Sone J, Tanaka F, Koike H, Inukai A, Katsuno M, Yoshida M et al (2011) Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Neurology 76:1372–1376CrossRef

Yu WY, Xu ZY, Lee HY, Tokumaru A, Tan JMM, Ng A et al (2019) Identifying patients with neuronal intranuclear inclusion disease in Singapore using characteristic diffusion-weighted MR images. Neuroradiology 61:1281–1290CrossRef

10.

Omoto S, Hayashi T, Matsuno H, Higa H, Kameya S, Sengoku R et al (2018) Neuronal intranuclear hyaline inclusion disease presenting with childhood-onset night blindness associated with progressive retinal dystrophy. J Neurol Sci 388:84–86CrossRef

11.

Santoro MR, Bray SM, Warren ST (2012) Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol 7:219–245CrossRef

12.

Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A et al (2006) Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129:243–255CrossRef

13.

Chen LZ, Chen AS, Lei S, He L, Zhou MK (2019) Teaching NeuroImages: the zigzag edging sign of adult-onset neuronal intranuclear inclusion disease. Neurology 92:E2295–E2296CrossRef

14.

Morimoto S, Hatsuta H, Komiya T, Kanemaru K, Tokumaru AM, Murayama S (2017) Simultaneous skin-nerve-muscle biopsy and abnormal mitochondrial inclusions in intranuclear hyaline inclusion body disease. J Neurol Sci 372:447–449CrossRef

15.

Sone J, Kitagawa N, Sugawara E, Iguchi M, Nakamura R, Koike H et al (2014) Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy. J Neurol Neurosurg Psychiatry 85:354–356CrossRef

16.

Fujita K, Osaki Y, Miyamoto R, Shimatani Y, Abe T, Sumikura H et al (2017) Neurologic attack and dynamic perfusion abnormality in neuronal intranuclear inclusion disease. Neurol-Clin Pract 7:E39–E42CrossRef

17.

Suthiphosuwan S, Sasikumar S, Munoz DG, Chan DK, Montanera WJ, Bharatha A (2019) MRI diagnosis of neuronal intranuclear inclusion disease leukoencephalopathy. Neurol-Clin Pract 9:497–499CrossRef

18.

Xiao F, Tian X, Wang XF (2018) Cerebral atrophy and leukoencephalopathy in a young man presenting with encephalitic episodes. JAMA Neurol 75:1563–1564CrossRef

19.

Nakamura M, Ueki S, Kubo M, Yagi H, Sasaki R, Okada Y et al (2018) Two cases of sporadic adult-onset neuronal intranuclear inclusion disease preceded by urinary disturbance for many years. J Neurol Sci 392:89–93CrossRef

20.

Guo J-J, Wang Z-Y, Wang M, Jiang Z-Z, Yu X-F (2020) Neuronal intranuclear inclusion disease mimicking acute cerebellitis: a case report. World J Clin Cases 8:6122–6129CrossRef

21.

Qin X, Chen H, Zhou C, Wang X, Gao J, Guo N et al (2021) Neuronal intranuclear inclusion disease: two case report and literature review. Neurol Sci 42:293–296CrossRef

22.

Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S et al (2016) Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain 139:3170–3186CrossRef

23.

Harigaya Y, Nakano Y, Hatsuta H, Sato M, Mizushima K, Murayama S (2016) Clinical features of adult-onset neuronal intranuclear inclusion disease. Eur J Neurol 23:346–346CrossRef

24.

Liu XY, Liu XH, Du YF, Lin YT, Li CX, Liu CC et al (2019) A case of recurrent vomiting: extending the spectrum of neuronal intranuclear inclusion disease. Neurol Sci 40:2661–2664CrossRef

25.

Munoz-Garcia D, Ludwin SK (1986) Adult-onset neuronal intranuclear hyaline inclusion disease. Neurology 36:785–790CrossRef

26.

Kulikova-Schupak R, Knupp KG, Pascual JM, Chin SS, Kairam R, Patterson MC (2004) Rectal biopsy in the diagnosis of neuronal intranuclear hyaline inclusion disease. J Child Neurol 19:59–62CrossRef

27.

Yokoi S, Yasui K, Hasegawa Y, Niwa K, Noguchi Y, Tsuzuki T et al (2016) Pathological background of subcortical hyperintensities on diffusion-weighted images in a case of neuronal intranuclear inclusion disease. Clin Neuropathol 35:375–380CrossRef

28.

Yamaguchi N, Mano T, Ohtomo R, Ishiura H, Almansour MA, Mori H et al (2018) An autopsy case of familial neuronal intranuclear inclusion disease with dementia and neuropathy. Intern Med 57:3459–3462CrossRef

29.

Michaud J, Gilbert JJ (1981) Multiple system atrophy with neuronal intranuclear hyaline inclusions. Report of a new case with light and electron microscopic studies. Acta Neuropathol 54:113–119CrossRef

30.

Mori F, Tanji K, Miki Y, Toyoshima Y, Sasaki H, Yoshida M et al (2018) Immunohistochemical localization of exoribonucleases (DIS3L2 and XRN1) in intranuclear inclusion body disease. Neurosci Lett 662:389–394CrossRef

31.

Pountney DL, Raftery MJ, Chegini F, Blumbergs PC, Gai WP (2008) NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture. Acta Neuropathol 116:603–614CrossRef

32.

Ishiura H, Shibata S, Yoshimura J, Suzuki Y, Qu W, Doi K et al (2019) Noncoding CGG repeat expansions in neuronal intranuclear inclusion dis ease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet 51:1222–1232CrossRef

33.

Sun QY, Xu Q, Tian Y, Hu ZM, Qin LX, Yang JX et al (2020) Expansion of GGC repeat in the human-specific NOTCH2NLC gene is associated with essential tremor. Brain 143:222–233CrossRef

Titel: Clinicopathological features of neuronal intranuclear inclusion disease diagnosed by skin biopsy
verfasst von: Gao-Jia Zhang
Di Wu
Yi-Xin Zhu
Hai-Feng Ni
Zhi-Jun Zhang
Publikationsdatum: 13.08.2021
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 3/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05526-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Study objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

Addiction-induced plasticity in underlying neural circuits

Tongue and cerebellar atrophy

Clinical heterogeneity in patients with myoclonus associated to COVID-19

New-onset status epilepticus in SARS-CoV-2 infection: a case series

Short- and long-term motor outcome of STN-DBS in Parkinson’s Disease: focus on sex differences